Back in 2010 the company was still basically Thrifty Printing and those compounds you mention were actually photocopies of chemical recipes for compounds that had not actually been made. The uplisting to amex in 2010 could actually have happened if it wasn't for a chronic printer jam that would not quit. Uplisting paperwork never made it. Basically this company was a front for a prostitution ring but this one #$%$ happened to be a chemist on the side and after the company bigshots partied her into a comatose state one Vegas weekend (courtesy shareholder $$$ of course!), they rifled through her bags and unexpectedly came across her plans for 2-73. A couple cinder-blocks in the ocean later and a cooked-up story about some Greek scientist (ever hear a peep from him? -- didn't think so), the Thrifty scam had somehow stumbled its way into being a real scientific operation, ha. You just can't make this stuff up.
The poster title for AAIC already tells us that we'll definitely get data at AAIC, and that those data are great (since any cognitive improvement in Alzheimer's is great compared to the SOC, especially in ADCS-ADL where we already know the 12-wk data is amazing). The only question is whether Anavex will give both a poster and an oral presentation, or just a poster. Either way, the poster title already tells us definitively that we will get both 12-wk raw efficacy data and 12-wk PK/PD analysis (and perhaps a look at some 26-wk data as well).